A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects

Clinical trial NCT06576401 · RECRUITING

Trial details

NCT number: NCT06576401
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subject

Start date: 2024-08-27
Primary completion: 2024-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.